发明申请
US20110196020A1 TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3)
审中-公开
使用TOLL-LIKE受体3(TLR3)的选择性激素治疗慢性疲劳综合征
- 专利标题: TREATMENT OF CHRONIC FATIGUE SYNDROME USING SELECTIVE AGONISTS OF TOLL-LIKE RECEPTOR 3 (TLR3)
- 专利标题(中): 使用TOLL-LIKE受体3(TLR3)的选择性激素治疗慢性疲劳综合征
-
申请号: US12998339申请日: 2009-10-13
-
公开(公告)号: US20110196020A1公开(公告)日: 2011-08-11
- 发明人: William A. Carter , David Strayer
- 申请人: William A. Carter , David Strayer
- 优先权: US61136889 20081010
- 国际申请: PCT/US2009/005576 WO 20091013
- 主分类号: A61K31/713
- IPC分类号: A61K31/713 ; C07H21/02 ; A61P43/00 ; A61P37/00
摘要:
A subset of human patients having chronic fatigue syndrome and impaired physical performance is treated using one or more different double-stranded ribonucleic acids (dsRNA) or other selective agonists of Toll-like receptor 3 (TLR3).